These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6429 related articles for article (PubMed ID: 2715660)

  • 21. Nonhaem complexes of FeIII stimulate cell attachment and growth by a mechanism different from that of serum, 2-oxocarboxylates, and haemproteins.
    Kay GF; Ellem KA
    J Cell Physiol; 1986 Feb; 126(2):275-84. PubMed ID: 3944209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OER and RBE for 125I and 192Ir at low dose rate on mammalian cells.
    Hering ER; Sealy GR; Dowman P; Blekkenhorst G
    Radiother Oncol; 1987 Nov; 10(3):247-52. PubMed ID: 3432600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic basis of metastases.
    McMenamin MM; Hayle AJ; Darling DL; Whittaker PA; Tutty MB; Clarke PJ; Tarin D
    Adv Exp Med Biol; 1988; 233():269-79. PubMed ID: 3223386
    [No Abstract]   [Full Text] [Related]  

  • 24. S-100 protein as a marker for melanocytic and other tumours.
    Cochran AJ; Wen DR
    Pathology; 1985 Apr; 17(2):340-5. PubMed ID: 2995906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma.
    Tsuboi T; Kondoh H; Hiratsuka J; Mishima Y
    Pigment Cell Res; 1998 Oct; 11(5):275-82. PubMed ID: 9877098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC-peptide binding: dimers of cysteine-containing nonapeptides bind with high affinity to HLA-A2.1 class I molecules.
    Di Modugno F; Mammi C; Rosanò L; Rubiu O; Nisticò P; Chersi A
    J Immunother; 1997 Nov; 20(6):431-6. PubMed ID: 9409448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of experimental subcutaneous human melanoma with a replication-restricted herpes simplex virus mutant.
    Randazzo BP; Bhat MG; Kesari S; Fraser NW; Brown SM
    J Invest Dermatol; 1997 Jun; 108(6):933-7. PubMed ID: 9182825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immune response to DNP-modified autologous cells after treatment with a DNP-conjugated melanoma vaccine.
    Sato T; Maguire HC; Mastrangelo MJ; Berd D
    Clin Immunol Immunopathol; 1995 Jan; 74(1):35-43. PubMed ID: 7994925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53.
    Jiang H; Lin J; Su ZZ; Collart FR; Huberman E; Fisher PB
    Oncogene; 1994 Nov; 9(11):3397-406. PubMed ID: 7936668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity.
    Abdel-Wahab ZA; Osanto S; Darrow TL; Barber JR; Vervaert CE; Gangavalli R; McCallister TJ; Seigler HF
    Cancer Gene Ther; 1994 Sep; 1(3):171-9. PubMed ID: 7621248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bouvardin (NSC 259968) on the growth characteristics an nucleic acids and protein syntheses profiles of P388 leukemia cells.
    Chitnis MP; Alate AD; Menon RS
    Chemotherapy; 1981; 27(2):126-30. PubMed ID: 7471902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms.
    Sava G; Zorzet S; Giraldi T; Mestroni G; Zassinovich G
    Eur J Cancer Clin Oncol; 1984 Jun; 20(6):841-7. PubMed ID: 6540184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of pigmentation by continuous X-irradiation of amelanotic tumors of B16-XI mouse melanoma and induced change in chromosomes of amelanotic cells.
    Ohara H; Kubo E; Furuse T; Nojiri I; Kasuga T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 41(3):267-76. PubMed ID: 6135271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theophylline and melanocyte-stimulating hormone effects on gamma-glutamyl transpeptidase and DOPA reactions in cultured melanoma cells.
    Hu F
    J Invest Dermatol; 1982 Jul; 79(1):57-62. PubMed ID: 6123537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunotherapy of cancer with BCG].
    Yamamura Y; Azuma I
    Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
    [No Abstract]   [Full Text] [Related]  

  • 36. Karyometrical and cytochemical studies of Harding-Passey melanoma and Horning-Mitchely kidney tumour. II. Cytochemistry of nucleic acids and proteins.
    el-Fiky SM; Fahmy TY; Abdo SE
    Acta Histochem; 1972; 42(1):106-14. PubMed ID: 4115317
    [No Abstract]   [Full Text] [Related]  

  • 37. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas. Twenty years' experience.
    Lommatzsch PK
    Am J Clin Oncol; 1987 Apr; 10(2):146-51. PubMed ID: 3565313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-melanoma activity of inulin in mice.
    Cooper PD; Carter M
    Mol Immunol; 1986 Aug; 23(8):903-8. PubMed ID: 3540619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Piperazinedione in patients with advanced malignant melanoma: a Southwest Oncology Group study.
    Al-Sarraf M; Thigpen T; Groppe CW; Haut A; Padilla F
    Cancer Treat Rep; 1978 Jul; 62(7):1101-3. PubMed ID: 356973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis for thymidine modulation of the efficacy and toxicity of alkylating agents.
    Hwu WJ; Mozdziesz DE
    Pharmacol Ther; 1997; 76(1-3):101-16. PubMed ID: 9535172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 322.